期刊文献+

系统性硬化症并间质性肺疾病与外周血 T细胞亚群的相关性研究 被引量:2

Correlation between peripheral blood T cell subsets and systemic sclerosis associated interstitial lung disease
下载PDF
导出
摘要 目的探讨系统性硬化症(SSc)并间质性肺疾病(ILD)与外周血T细胞亚群的相关性。方法选取2018年1月至2020年12月期间海南医学院第一附属医院风湿免疫科收治的40例SSc患者为研究对象,所有患者均给予外周血T细胞亚群水平检测,并采用高分辨率CT扫描对SSc患者进行ILD分级。根据SSc患者是否合并ILD分为SSc-ILD组和SSc-Non-ILD组,比较两组患者外周血CD3^(+)、CD4^(+)、CD8^(+)、CD4^(+)/CD8^(+)水平。采用Pearson检验分析SSc患者ILD分级与外周血T细胞亚群水平的相关性,绘制受试者工作特性(ROC)曲线分析外周血T细胞亚群水平对SSc-ILD的最佳截断值、敏感度、特异度。结果SSc-ILD组和SSc-Non-ILD组患者的CD8^(+)[(33.64±7.28)vs(29.56±6.52)]水平比较,SSc-ILD组明显高于SSc-Non-ILD组,CD3^(+)[(66.73±11.32)vs(70.51±10.84)]、CD4^(+)/CD8^(+)[(1.13±0.25)vs(1.58±0.35)]水平比较,SSc-ILD组明显低于SSc-Non-ILD组,差异均有统计学意义(P<0.05);经Pearson相关性分析结果显示,SSc患者ILD分级与CD3^(+)、CD4^(+)/CD8^(+)呈负相关(r=-0.755、-0.659,P<0.05),与CD8^(+)呈正相关性(r=0.845,P<0.05);ROC曲线分析结果显示,CD3^(+)、CD8^(+)、CD4^(+)/CD8^(+)水平对SSc-ILD的曲线下面积(AUC)分别为0.745、0.797、0.667,最佳截断值分别为67.65、32.70、1.29,敏感度分别为79.2%、83.8%、75.0%,特异度分别为68.4%、71.1%、73.7%。结论SSc患者免疫功能紊乱与其并发ILD密切相关,外周血CD3^(+)、CD8^(+)、CD4^(+)/CD8^(+)水平改变对SSc-ILD病情评估和临床诊断具有重要的价值。 Objective To explore the correlation between peripheral blood T cell subsets and systemic sclerosis(SSc)associated interstitial lung disease(ILD).Methods From January 2018 to December 2020,40 patients with SSc admitted to the Department of Nephrology and Rheumatology,the First Affiliated Hospital of Hainan Medical College were selected as the research objects.All patients were given peripheral blood T cell subsets level detection,and high-resolution CT scanning was used to grade the ILD of SSc patients.The patients with SSc were divided into SSc-ILD group and SSc-Non-ILD group according to whether they were combined with ILD.The levels of CD3^(+),CD4^(+),CD8^(+),CD4^(+)/CD8^(+)in peripheral blood of the two groups were compared.Pearson test was used to analyze the correlation between ILD grading and peripheral blood T cell subsets in SSc patients.Receiver operating characteristic(ROC)curve was drawn to analyze the optimal cutoff values,sensitivity and specificity of peripheral blood T cell subsets to SSc-ILD.Results The level of CD8^(+)in SSc-ILD group was(33.64±7.28)versus(29.56±6.52)in SSc-Non-ILD group,and the levels of CD3^(+),CD4^(+)/CD8^(+)were(66.73±11.32)and(1.13±0.25),respectively,which were significant lower than corresponding(70.51±10.84)and(1.58±0.35)in SSc-Non-ILD group(P<0.05).Pearson correlation test showed that ILD grade of SSc patients was negatively correlated with CD3^(+),CD4^(+)/CD8^(+)(r=-0.755,-0.659,P<0.05),and positively correlated with CD8^(+)(r=0.845,P<0.05).ROC curve analysis showed that areas under curve(AUC)of CD3^(+),CD8^(+)and CD4^(+)/CD8^(+)levels to SSc-ILD were 0.745,0.797 and 0.667,respectively.The optimal cutoff values were 67.65,32.70 and 1.29,respectively.The sensitivity was 79.2%,83.8%,and 75.0%,and the specificity was 68.4%,71.1%,and 73.7%,respectively.Conclusion Immune dysfunction is closely related to ILD in SSc patients,and the changes of CD3^(+),CD8^(+),and CD4^(+)/CD8^(+)levels in peripheral blood are of great value in the assessment and clinical diagnosis of SSc-ILD.
作者 李国铨 郭峰 王敏 叶凤 郑颜萍 LI Guo-quan;GUO Feng;WANG Min;YE Feng;ZHENG Yan-ping(Department of Rheumatology and Immunology,the First Affiliated Hospital of Hainan Medical University,Haikou 570100,Hainan,CHINA)
出处 《海南医学》 CAS 2021年第14期1789-1793,共5页 Hainan Medical Journal
基金 海南省卫生计生行业科研项目(编号:18A200101)。
关键词 系统性硬化症 间质性肺疾病 外周血T细胞亚群 相关性研究 Systemic sclerosis(SSc) Interstitial lung disease(ILD) Peripheral blood T cell subsets Correlation study
  • 相关文献

参考文献13

二级参考文献45

  • 1朱元珏.间质性肺疾病的诊断和治疗进展[J].临床肺科杂志,2007,12(1):1-4. 被引量:24
  • 2Au K,Khanna D,Clements PJ. Current concepts in disease-modifying therapy for systemic sclerosis-associated interstitial lung disease:lessons from clinical trials[J].Curr Rheureatol Rep,2009,(02):111-119.
  • 3Subcommittee for Scleroderma Criteria of the American Rheunmtism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma)[J].Arthritis and Rheumatism,1980,(05):581-590.
  • 4Ryu JH,Daniels CE,Hartman TE. Diagnosis of interstitial lung diseases[J].Mayo Clinic Proceed,2007,(08):976-986.
  • 5Van der Kamp R,Tak PP,Jansen HM. Interstitial lung disease as the first manifestation of systemic sclerosis[J].Netherlands Journal of Medicine,2007,(10):390-394.
  • 6Hamaguchi Y. Autoantibody pmfiles in systemic sclerosis:predictive value for clinical evaluation and prognosis[J].Journal of Dermatology,2010,(01):42-53.
  • 7Desai SR,Veeraraghavan S,Hansell DM. CT features of lung disease in patients with systemic sclerosis:comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia[J].Radiology,2004,(02):560-567.
  • 8Bourns D,Wells AU,Nieholson AG. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome[J].American Journal of Respiratory and Critical Care Medicine,2002,(12):1581-1586.
  • 9Rsghu G,Megeto YN,Lockhart D. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease:a prospective study[J].Chest,1999,(05):1168-1174.
  • 10Behr J,Furst DE. Pulmonary function tests[J].Bheumatology,2008,(05):65-67.

共引文献28

同被引文献17

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部